BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends one-time hepatitis C virus (HCV) antibody testing for "Birth Cohort" adults born during 1945-1965. OBJECTIVE: To examine the impact of an electronic health record (EHR)-embedded best practice alert (BPA) for HCV testing among Birth Cohort adults. DESIGN: Cluster-randomized trial was conducted from April 29, 2013 to March 29, 2014. SUBJECTS AND SETTING:Ten community and hospital-based primary care practices. Participants were attending physicians and medical residents during 25,620 study-eligible visits. INTERVENTION: Physicians in all practices received a brief introduction to the CDC testing recommendations. At visits for eligible patients at intervention sites, physicians received a BPA through the EHR to order HCV testing or medical assistants were prompted to post a testing order for the physician. Physicians in control sites did not receive the BPA. MAIN OUTCOMES: HCV testing; the incidence of HCV antibody positive tests was a secondary outcome. RESULTS:Testing rates were greater among Birth Cohort patients in intervention sites (20.2% vs. 1.8%, P<0.0001) and the odds of testing were greater in intervention sites after controlling for imbalances of patient and visit characteristics between comparison groups [odds ratio (OR), 9.0; 95% confidence interval, 7.6-10.7). The adjusted OR of identifying HCV antibody positive patients was also greater in intervention sites (OR, 2.1; 95% confidence interval, 1.3-11.2). CONCLUSIONS: An EHR-embedded BPA markedly increased HCV testing among Birth Cohort patients, but the majority of eligible patients did not receive testing indicating a need for more effective methods to promote uptake.
RCT Entities:
BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends one-time hepatitis C virus (HCV) antibody testing for "Birth Cohort" adults born during 1945-1965. OBJECTIVE: To examine the impact of an electronic health record (EHR)-embedded best practice alert (BPA) for HCV testing among Birth Cohort adults. DESIGN: Cluster-randomized trial was conducted from April 29, 2013 to March 29, 2014. SUBJECTS AND SETTING: Ten community and hospital-based primary care practices. Participants were attending physicians and medical residents during 25,620 study-eligible visits. INTERVENTION: Physicians in all practices received a brief introduction to the CDC testing recommendations. At visits for eligible patients at intervention sites, physicians received a BPA through the EHR to order HCV testing or medical assistants were prompted to post a testing order for the physician. Physicians in control sites did not receive the BPA. MAIN OUTCOMES: HCV testing; the incidence of HCV antibody positive tests was a secondary outcome. RESULTS: Testing rates were greater among Birth Cohort patients in intervention sites (20.2% vs. 1.8%, P<0.0001) and the odds of testing were greater in intervention sites after controlling for imbalances of patient and visit characteristics between comparison groups [odds ratio (OR), 9.0; 95% confidence interval, 7.6-10.7). The adjusted OR of identifying HCV antibody positive patients was also greater in intervention sites (OR, 2.1; 95% confidence interval, 1.3-11.2). CONCLUSIONS: An EHR-embedded BPA markedly increased HCV testing among Birth Cohort patients, but the majority of eligible patients did not receive testing indicating a need for more effective methods to promote uptake.
Authors: David B Rein; John S Wittenborn; Cindy M Weinbaum; Miriam Sabin; Bryce D Smith; Sarah B Lesesne Journal: Dig Liver Dis Date: 2010-06-17 Impact factor: 4.088
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Matthew Bidwell Goetz; Tuyen Hoang; Candice Bowman; Herschel Knapp; Barbara Rossman; Robert Smith; Henry Anaya; Teresa Osborn; Allen L Gifford; Steven M Asch Journal: J Gen Intern Med Date: 2008-05-02 Impact factor: 5.128
Authors: Monica A Konerman; Mary Thomson; Kristen Gray; Meghan Moore; Hetal Choxi; Elizabeth Seif; Anna S F Lok Journal: Hepatology Date: 2017-09-14 Impact factor: 17.425
Authors: Mia J Biondi; Grishma Hirode; Camelia Capraru; Aaron Vanderhoff; Joel Karkada; Brett Wolfson-Stofko; David Smookler; Steven M Friedman; Kathy Bates; Tony Mazzulli; Joshua V Juan; Hemant Shah; Bettina E Hansen; Jordan J Feld; Harry LA Janssen Journal: Can Liver J Date: 2022-08-16
Authors: Monica L Kasting; Shannon M Christy; Richard R Reich; Julie A Rathwell; Richard G Roetzheim; Susan T Vadaparampil; Anna R Giuliano Journal: Public Health Rep Date: 2021-10-25 Impact factor: 3.117
Authors: Eric Chak; Amir Taefi; Chin-Shang Li; Moon S Chen; Aaron M Harris; Scott MacDonald; Christopher Bowlus Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-08-08 Impact factor: 4.254
Authors: Robin T Higashi; Mamta K Jain; Lisa Quirk; Nicole E Rich; Akbar K Waljee; Barbara J Turner; Simon Craddock Lee; Amit G Singal Journal: J Viral Hepat Date: 2020-03-02 Impact factor: 3.728
Authors: Lauren E Cipriano; Shan Liu; Kaspar S Shahzada; Mark Holodniy; Jeremy D Goldhaber-Fiebert Journal: Med Decis Making Date: 2018-08-22 Impact factor: 2.583